Trial intelligence / Profile preview

L-NAME for Prevention of Low Blood Pressure in Tetraplegia

NCT00237770Phase 3Completed

Sponsor
United States Department of Veterans Affairs
Start
Jun 2003
Primary completion
Jun 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ng-nitro-l-arginine methyl ester in orthostatic hypotension (OH), sponsored by United States Department of Veterans Affairs. Started Jun 2003; status: completed.

02

Drugs

ng-nitro-l-arginine methyl ester
03

Conditions

orthostatic hypotension (OH)

Beyond the preview

Go deeper on NCT00237770.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00237770.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call